Valentina Baez Sosa, MD

home / authors / valentina-baez-sosa-md

Articles

Valentina Baez Sosa, MD, of MedStar Washington Hospital Center

Gymnastics Makes Me a Better Oncologist

Valentina Baez Sosa, MD
September 2nd 2021

Valentina Baez Sosa, MD, shares how her early life experiences in gymnastics and coaching have helped her become a better hematology/oncology physician.

Read More

Valentina Baez Sosa, MD, of MedStar Washington Hospital Center

COVID-19 Inspires a New Mantra for Wellness

Valentina Baez Sosa, MD
May 23rd 2021

The COVID-19 pandemic has inspired a new mantra for wellness in the oncology community and beyond.

Read More

Latest Updated Articles

Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors
Published: August 22nd 2024 | Updated: August 29th 2024
Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors
Long-term Follow-up of Selinexor Maintenance for Patients With TP53wt Advanced or Recurrent Endometrial Cancer: A Prespecified Subgroup Analysis From the Phase 3 ENGOT-EN5/GOG-3055/SIENDO Study
Published: August 6th 2024 | Updated: August 19th 2024
Long-term Follow-up of Selinexor Maintenance for Patients With TP53wt Advanced or Recurrent Endometrial Cancer: A Prespecified Subgroup Analysis From the Phase 3 ENGOT-EN5/GOG-3055/SIENDO Study
Sarwish Rafiq, PhD
Published: July 9th 2024 | Updated: July 10th 2024
Dr Rafiq on Novel Strategies for CAR T-Cell Engineering in Solid Tumors
Jens Hoeppner, FAChirg, FACS, MD
Published: June 2nd 2024 | Updated: June 3rd 2024
Perioperative Chemotherapy Prolongs OS vs Neoadjuvant Chemoradiation in Esophageal Cancer
Peter Schmid, MD, PhD, Barts College
Published: September 15th 2024 | Updated: September 16th 2024
Neoadjuvant Pembrolizumab/Chemo, Adjuvant Pembrolizumab Boosts OS in Early TNBC
Toni Choueiri, MD, of Dana-Farber Cancer Institute
Published: September 13th 2024 | Updated: September 16th 2024
Tivozanib Monotherapy Bests Lower-Dose Tivozanib Plus Nivolumab in Metastatic RCC